As Chief Financial Officer, Yogesh Bahl oversees the corporate finance and investor relations functions at IACTA.
Mr. Bahl previously served as Managing Director at AlixPartners from 2013 through 2021. At AlixPartners, he was the global co-lead for the Healthcare & Life Sciences practice responsible for financial advisory and improvement services provided to healthcare and life sciences companies around the world. In this role, Mr. Bahl focused on improving customer-product-profitability, gross to net, and payor management operations at private equity portfolio companies as part of enterprise-wide transformation efforts to increase growth and productivity. Mr. Bahl also served as a financial expert in various matters involving business transactions and strategic alliances. Prior to AlixPartners, Mr. Bahl spent seventeen years at Deloitte, where he most recently served as Partner and was responsible for the life sciences financial advisory practice in the United States. At Deloitte, Mr. Bahl also served on the audit teams of Bristol Myers Squibb and Abbott Laboratories. Previously, Mr. Bahl held accounting, auditing, and investigative positions at TIAA-CREF and Sargoy, Stein, Rosen & Shapiro.
Mr. Bahl received his Master of Business Administration in finance and statistics, as well as his Bachelor of Science in accounting and international business from New York University’s Stern School of Business.